Grupo MIL promotes equity and diversity in interventional cardiology at SOLACI-SOCIME 2025

As part of the SOLACI-SOCIME 2025 Congress, the most important interventional cardiology event in Latin America, a notable scientific session was held at Expo Santa Fe, organized by the Grupo de Mujeres Intervencionistas Latinoamericanas (MIL).

Under the title “Equity and Diversity in Interventional Cardiology: Why Is It Important?”, the session brought together renowned specialists from across the region, who shared experiences, strategies, and reflections on the role of gender equity and diversity in the field. The session was coordinated by María Antonieta Albanez and Fernanda Mangione (Brazil), with a distinguished panel of experts including Ludimilla Tartuce (Brazil), Anahí Florencio (Argentina), Andrea Robaina (Venezuela), and Guadalupe Jiménez (Mexico).

The program featured high-level academic presentations:

  • Patricia Aubanel (Mexico) presented Inspiring Stories of Women Who Have Reached Prominent Positions, sharing lessons learned and strategies for professional growth.
  • María Antonieta Albanez (Brazil) offered practical recommendations on Participation in Congresses and Scientific Publications, covering the preparation of competitive abstracts, impactful presentations, and strengthening of the academic CV.
  • María Sanali Paiva (Brazil) spoke on Gender Equity and Institutional Leadership, highlighting the importance of inclusive policies.
  • Finally, Emma Miranda (Mexico) and Carla Agatiello (Argentina) interviewed renowned specialist Mayra Guerrero on Leadership Pathways of Women in Interventional Cardiology.

    The session was a testament to the commitment of SOLACI-SOCIME and the MIL Group to promoting diversity, highlighting female leadership, and strengthening the Latin American scientific community in interventional cardiology. The quality of the presentations and the expertise of the participants reaffirmed the value of these spaces for advancing the specialty in the region.


    Subscribe to our weekly newsletter

    Get the latest scientific articles on interventional cardiology

     

    More articles by this author

    Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

    Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

    Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

    Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

    25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

    The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

    SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

    The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Related Articles

    SOLACI Sessionsspot_img

    Recent Articles

    Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

    Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

    Is it really necessary to monitor all patients after TAVR?

    Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

    Is it really necessary to monitor all patients after TAVR?

    Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....